Profil
Susan Whichard is currently a Non-Executive Director at Neuromod Devices Ltd.
She previously worked as Vice President-Consumer & Professional Services at InSound Medical, Inc. in 2011.
Aktive Positionen von Susan Whichard
| Unternehmen | Position | Beginn |
|---|---|---|
Neuromod Devices Ltd.
 Neuromod Devices Ltd. Medical SpecialtiesHealth Technology Neuromod Devices Ltd. operates as a medical device company which engages in the research and development of neuromodulation technologies for chronic tinnitus. The firm develops proprietary neuromodulation technologies designed to address pathologies, which are believed to give rise to illusory perceptions, such as tinnitus. These technologies utilize bi-modal neuromodulation and aim to promote positive therapeutic change within the human nervous system. The company was founded by Ross O?Neill in 2010 and is headquartered in Dublin, Ireland. | Direktor/Vorstandsmitglied | 16.08.2021 |
Ehemalige bekannte Positionen von Susan Whichard
| Unternehmen | Position | Ende |
|---|---|---|
InSound Medical, Inc.
 InSound Medical, Inc. Medical SpecialtiesHealth Technology InSound Medical, Inc. developed and manufactured hearing devices. The company was founded in 1998 and was headquartered in Newark, CA. | Corporate Officer/Principal | 20.10.2011 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
InSound Medical, Inc.
InSound Medical, Inc. Medical SpecialtiesHealth Technology InSound Medical, Inc. developed and manufactured hearing devices. The company was founded in 1998 and was headquartered in Newark, CA. | Health Technology |
Neuromod Devices Ltd.
Neuromod Devices Ltd. Medical SpecialtiesHealth Technology Neuromod Devices Ltd. operates as a medical device company which engages in the research and development of neuromodulation technologies for chronic tinnitus. The firm develops proprietary neuromodulation technologies designed to address pathologies, which are believed to give rise to illusory perceptions, such as tinnitus. These technologies utilize bi-modal neuromodulation and aim to promote positive therapeutic change within the human nervous system. The company was founded by Ross O?Neill in 2010 and is headquartered in Dublin, Ireland. | Health Technology |
